The results of two international studies carried out at dozens of trial centers worldwide show for the first time that eltrombopag is a safe and effective treatment for children with persistent or chronic immune thrombocytopenia – a rare bleeding disorder where the blood does not clot as it should, due to low numbers of blood platelets.

Continue reading Treatment for rare bleeding disorder effective and well-tolerated, studies show →